Skip to main content

Table 1 Inadequate Biological and Haematological Indices

From: Clinical trial protocol for TARDOX: a phase I study to investigate the feasibility of targeted release of lyso-thermosensitive liposomal doxorubicin (ThermoDox®) using focused ultrasound in patients with liver tumours

Laboratory Test Exclusion Criteria
International Normalised Ratio > 1.5 times the institution’s upper normal limit (unless anti-coagulated)
Absolute neutrophil count <1500/mm3 (or <1.5 (109/L))
Platelet count < 60,000 /mm3 (or <60 (109/L))
Haemoglobin < 9.0 g/dL
Serum creatinine
Calculated creatinine clearance (CrCl)
≥ 2.5 mg/dL (or ≥221 μmol/L)
≤ 25.0 mL/min
Serum bilirubin > 3.0 mg/dL (or >51 μmol/L)
Serum albumin < 2.8 g/dL (or <28g/L)